Hotline sessions and clinical trial updates presented at the European Society of Cardiology Congress in Stockholm 2010

Clinical Research in Cardiology

Volumn 99, Issue 11, 2010, Pages 679-692

  Lenski, Matthias ^a   Mahfoud, Felix ^a   Werner, Christian ^a   Bauer, Axel ^b   Böhm, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

ALPHA OMEGA; ANTIPAF; ART; ATOLL; AVERROES; CARE HF LTFU; COPPS; DANPACE; E5555; EINSTEIN DVT; EVOLUTION; FUTURA OASIS 8; GRACE; HEBE III; INNOVATE PCI; ISAR REACT 3A; LESSON I; PACE; PEARL HF; SHIFT; SOURCE REGISTRY TAVI

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; APIXABAN; ARGATROBAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; E 5555; ELINOGREL; ENOXAPARIN; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRUDIN; HIRULOG; ICOSAPENTAENOIC ACID; IVABRADINE; LINOLENIC ACID; OLMESARTAN; PACLITAXEL; PLACEBO; PRT 060128; RLY 5016; SPIRONOLACTONE; THROMBIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORAXAPAR; WARFARIN;

ACUTE CORONARY SYNDROME; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG MEGADOSE; EMBOLISM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART RATE VARIABILITY; HUMAN; HYPERKALEMIA; LOW DRUG DOSE; MEDICAL LITERATURE; MEDICAL SOCIETY; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; UNSPECIFIED SIDE EFFECT;

CARDIOLOGY; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; HUMANS; SOCIETIES, MEDICAL; SWEDEN;

EID: 78649639988     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0238-3     Document Type: Review

References (22)

1. SH Schirmer, et al. 2009 Hotlines and clinical trial updates presented at the European Society of Cardiology Meeting 2009: data from RE-LY, PLATO, MADIT-CRT, PROTECT, SYNTAX, TRITON and more Clin Res Cardiol 98 11 691 699 1:STN:280:DC%2BD1MjitFGnsw%3D%3D 10.1007/s00392-009-0085-2 19774327
2. K Swedberg, et al. 2010 Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 9744 875 885 1:CAS:528:DC%2BC3cXhtFCltrzO 10.1016/S0140-6736(10)61198-1 20801500
3. FA McAlister, et al. 2009 Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 11 784 794 19487713
4. M Böhm, et al. 2010 Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 9744 886 894 10.1016/S0140-6736(10)61259-7 20801495
5. Voors AA et al (2010) A single dose of erythropoietin in ST-elevation myocardial infarction. Eur Heart J
6. S Leonardi, et al. 2010 Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI) Am Heart J 160 1 65 72 1:CAS:528:DC%2BC3cXosVWnsr8%3D 10.1016/j.ahj.2010.04.008 20598974
7. Goto S et al (2010) Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease. Eur Heart J
8. G Montalescot, et al. 2006 Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention N Engl J Med 355 10 1006 1017 1:CAS:528:DC%2BD28XpsFKmtbY%3D 10.1056/NEJMoa052711 16957147 (Pubitemid 44343544)
9. Schulz S et al (2010) ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention. Eur Heart J
10. A Kastrati, et al. 2008 Bivalirudin versus unfractionated heparin during percutaneous coronary intervention N Engl J Med 359 7 688 696 1:CAS:528:DC%2BD1cXhtVSht7%2FN 10.1056/NEJMoa0802944 18703471
11. Wijns W et al (2010) Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J
12. Taggart DP et al (2010) Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). Eur Heart J
13. JW Eikelboom 2010 Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment Am Heart J 159 3 348 353 e1 1:CAS:528:DC%2BC3cXivFWgur0%3D 10.1016/j.ahj.2009.08.026 20211294
14. JR Ehrlich SH Hohnloser S Nattel 2006 Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence Eur Heart J 27 5 512 518 1:CAS:528:DC%2BD28Xjt1Krtrw%3D 10.1093/eurheartj/ehi668 16311236
15. E Vermes, et al. 2003 Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the studies of left ventricular dysfunction (SOLVD) trials Circulation 107 23 2926 2931 10.1161/01.CIR.0000072793.81076.D4 12771010 (Pubitemid 36736634)
16. Steg PG et al (2010) Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. JAMA
17. CM Yu, et al. 2009 Biventricular pacing in patients with bradycardia and normal ejection fraction N Engl J Med 361 22 2123 2134 10.1056/NEJMoa0907555 19915220
18. JG Cleland, et al. 2005 The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 15 1539 1549 1:CAS:528:DC%2BD2MXjtFGnsLo%3D 10.1056/NEJMoa050496 15753115 (Pubitemid 40517094)
19. B Maisch, et al. 2004 Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European society of cardiology Eur Heart J 25 7 587 610 10.1016/j.ehj.2004.02.002 15120056 (Pubitemid 38478552)
20. Y Finkelstein, et al. 2002 Colchicine for the prevention of postpericardiotomy syndrome Herz 27 8 791 794 10.1007/s00059-002-2376-5 12574898 (Pubitemid 36105568)
21. Imazio M et al (2010) COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J [Epub ahead of print]
22. S Leontyev, et al. 2009 Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE Ann Thorac Surg 87 5 1440 1445 10.1016/j.athoracsur.2009.01.057 19379882